NCT06161571 · Interventional trial
A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Overall registry status Active not recruiting
Phase 3
Conditions NAFLD/MASLD, NASH/MASH
Delaware Valley sites
- Akero Clinical Study Site · Philadelphia, PA · Philadelphia County
- Akero Clinical Study Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory